Researcher
Brant Delafontaine
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Education curriculum, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Basic and Applied Medical Sciences (Department)
Member
From1 Oct 2018 → 31 May 2019 - Department of Pharmacology (Department)
Member
From1 Jan 2014 → 30 Sep 2018
Publications
1 - 9 of 9
- Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer(2023)
Authors: Jonathan Chou, Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar, Jun Zhu, Tanushree Shenoy, Kai Trepka, Troy M. Robinson, et al.
Pages: 301 - 315 - PRECISION : the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment(2022)
Authors: J. Thouvenin, C. Van Marcke, L. Decoster, G. Raicevic, K. Punie, M. Vandenbulcke, R. Salgado, E. Van Valckenborgh, B. Maes, S. Joris, et al.
- Safety and immunogenicity of LY3415244, a bispecific antibody against TIM-3 and PD-L1, in patients with advanced solid tumors(2021)
Authors: Matthew D. Hellmann, Nicoletta Bivi, Boris Calderon, Toshio Shimizu, Brant Delafontaine, Zhuqing Tina Liu, Anna M. Szpurka, Victoria Copeland, F. Stephen Hodi, Philippe Aftimos, et al.
Pages: 2773 - 2781 - An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations(2020)
Authors: Brant Delafontaine, C. De Backer, B. Beuselinck, P. Debruyne, L. DU+2019Hondt, C. Gennigens, T. Gil, C. Vulsteke, N. Martinez-Chanza, A. Verbiest, et al.
Pages: 56 - 70 - Switchability of gabapentin formulations : a randomized trial to assess bioequivalence between Neurontin and Gabasandoz on the individual subject level(2019)
Authors: Lucas Van Bortel, Brant Delafontaine, Koen Boussery, Eleonora Swart, Abdel Chahbouni, Pieter Colin
Pages: 195 - 203 - Checkpoint inhibition : new treatment options in urologic cancer(2017)
Authors: Daan De Maeseneer, Brant Delafontaine
Pages: 24 - 28 - KH176 under development for rare mitochondrial disease : a first in man randomized controlled clinical trial in healthy male volunteers(2017)
Authors: Saskia Koene, Edwin Spaans, Lucas Van Bortel, Brant Delafontaine, Fabio Badilini, Julien Beyrath, Jan Smeitink
- Virussen in de behandeling van kanker : oncolytische virotherapie(2016)
Authors: Brant Delafontaine, Lucas Van Bortel
Pages: 29 - 35 - Evaluation of a Cerebral-Blood-Volume (CBV) pharmaco-MRI (phMRI) assay utilizing low (0.1mg/70kg) and high (0.2mg/70kg) dose buprenorphine infusion and a novel USPIO contrast agent (Ferumoxytol) in healthy human subjects(2015)Volume: 23
Authors: Richard Baumgartner, Arie Struyk, Jeff Evelhoch, Cynthia Gargano, Francheska Colon Gonzalez, Haiying Liu, Ruben Declercq, Hans Verheyden, Ingeborg Heirman, HANS DE PLA, et al.
Number of pages: 1